Leash Bio

Leash Bio is a startup based in the United States. Its most recent tracked round is Seed. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.

Leash Bio builds a proprietary dataset of billions of protein–molecule interaction measurements by screening millions of compounds against hundreds of protein targets, and uses this data to train machine learning models for designing novel molecules in drug discovery.